'ATMP Sweden' is the national network of Sweden's activities within medicines based on genes, cells or tissue engineering, classified as Advanced Therapy Medicinal Products (ATMPs) in Europe. Our goal is to promote the collaboration and communication needed for accelerated, effective ATMP based patient solutions.
Who are we?
Driving ATMP technological developments, research translation and manufacturing capabilities.
Competence Center for the development of next generation NK cell-based cancer immunotherapies.
Subscribe to our mailing list
Subscribe to receive our quarterly newsletter and updates on the next ATMP Sweden conference. ATMP Introductory course
Learn the basics for bringing ATMPs to patients!
15min online, free of charge! Available in English and Swedish.
Follow us on LinkedIn! News
ATMP Sweden newsletter June 2021
Including launch of our ATMP Introductory course!
Time for a new website!
ATMP Sweden is about to get a new look
Who is NEOGAP?
A Swedish precision medicine ATMP
The ATMP regulatory guide
Use this guide to navigate development of an ATMP through manufacture and Clinical Trial Application.
What are ATMPs?
The obvious, less obvious and ATMP related technologies
Did you know that bacteria expressing a human protein can be a ATMP/GTMP? Read more here about what types of treatments/products are classified as ATMPs and which ones are not.
INTRODUCTION TO ATMP COURSE
ATMP Sweden 2021 virtual
Other collaborating national projects
VOG cell is responsible for ensuring Swedish GMP manfacturing facilities function at the highest level and are compliant with current regulations.
AdBIOPRO is developing Continuous Processing of emerging potent therapeutic products such as recombinant viral vector and cell Products.
Sweden are world leader in NK cell research and this group are world leaders in NK cell therapies for patients!
See all ATMP relevant organisations